Jeff Merkley actually said...

Last, I wanted to raise the issue of drug shortages and drug scalping.

It does seem like using a flawed design as a foundation for approving another device under 510(k) is something that we need to wrestle with.

I am really hoping we can try to solve this problem because when patients are told, 'Well, we are partway through your cancer treatment, and...

we should add some investor protections, and we do require three different levels of information, depending on how much a company is raising...